Product Description: TPO agonist 1 is a thrombopoietin (TPO) agonist extracted from patent WO2008134338A1, compound TPO mimetic. It would be useful as promoters of thrombopoiesis and megakaryocytopoiesis to treat thrombocytopenia[1].
Applications: COVID-19-immunoregulation
Formula: C25H22N8O2
References: [1]Jerome Francis Hayes. Novel processes of making hydroxy-1-azo-derivatives as tpo mimetics. 6 November 2008. WO2008134338A1./[2]Siegal D et al. Thrombopoietin receptor agonists in primary immune thrombocytopenia.
et al. Semin Hematol. 2013 Jan;50 Suppl 1:S18-21